However, when mRNA sequence data were analyzed, higher CCL2 mRNA expression was associated with a poor OS in all patients with BC (HR 1.57) and patients with TNBC (HR 3.37), particularly with TNBC without lymph node metastasis (HR 290458404.16) (Fig. 5). The gene discussed is CCL2; the disease is breast cancer.